drugset
drugset / Trial / NCT04037072

Efficacy of Topical Mitomycin C for Complex Benign Esophageal Anastomotic Strictures

NCT04037072 ↗

Phase 2 Withdrawn Fox Chase Cancer Center
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study evaluates Mitomycin C as treatment for dysphagia in adult subjects with documented complex esophageal anastomotic strictures. Patients will be randomized in a double-blinded fashion to topical application of normal saline (NS) or Mitomycin C (MMC) at the time of time of index procedure.

Timeline

Start
2020-04-03
Primary completion
2022-03-15
Completion
2022-12-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Mitomycin C Other / unclassified 0.4 mg/ml Topical

Indications

No indication recorded.